About: Israel Cancer Research Fund     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:SocialGroup107950920, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon
http://dbpedia.demo.openlinksw.com/c/12W1ndwE4Z

The Israel Cancer Research Fund (ICRF) is a fund for cancer research. The ICRF was founded in 1975 by a group of American and Canadian physicians, scientists and lay people who sought to prevent the permanent loss of Israel's cancer researchers to foreign universities due to the lack of funding in Israel for newly minted Ph.D.s, post-doctoral fellows and accomplished young scientists (a phenomenon known to many as Israel's "brain drain"). With chapters in New York, Los Angeles, Chicago, Toronto, Montreal and Jerusalem, ICRF annually sponsors a grant review process conducted by an expert panel of U.S. and Canadian scientists and oncologists, and modeled on the NIH grant-making process.

AttributesValues
rdf:type
rdfs:label
  • Israel Cancer Research Fund (en)
rdfs:comment
  • The Israel Cancer Research Fund (ICRF) is a fund for cancer research. The ICRF was founded in 1975 by a group of American and Canadian physicians, scientists and lay people who sought to prevent the permanent loss of Israel's cancer researchers to foreign universities due to the lack of funding in Israel for newly minted Ph.D.s, post-doctoral fellows and accomplished young scientists (a phenomenon known to many as Israel's "brain drain"). With chapters in New York, Los Angeles, Chicago, Toronto, Montreal and Jerusalem, ICRF annually sponsors a grant review process conducted by an expert panel of U.S. and Canadian scientists and oncologists, and modeled on the NIH grant-making process. (en)
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
sameAs
dbp:wikiPageUsesTemplate
has abstract
  • The Israel Cancer Research Fund (ICRF) is a fund for cancer research. The ICRF was founded in 1975 by a group of American and Canadian physicians, scientists and lay people who sought to prevent the permanent loss of Israel's cancer researchers to foreign universities due to the lack of funding in Israel for newly minted Ph.D.s, post-doctoral fellows and accomplished young scientists (a phenomenon known to many as Israel's "brain drain"). With chapters in New York, Los Angeles, Chicago, Toronto, Montreal and Jerusalem, ICRF annually sponsors a grant review process conducted by an expert panel of U.S. and Canadian scientists and oncologists, and modeled on the NIH grant-making process. Awards are granted directly to the Israeli cancer researchers at all of the leading (more than 20) academic and biomedical research centers throughout Israel. ICRF has funded more than $63 million to-date in awards to Israeli cancer researchers via more than 2,349 fellowships, project grants, career development awards, and professorships. Grants have been provided to over 20 institutions including all major hospitals, universities, and cancer research projects throughout Israel. Breakthrough discoveries by ICRF-funded scientists have led to the development of: Gleevec -used in the successful treatment of chronic myelogenous leukemia; Doxil - used in the treatment of breast & ovarian cancer as well as AIDS; p53 – a key tumor suppressor; RAD 51 which identifies the likelihood of breast cancer occurring in women who carry the BRCA 2 gene and Velcade - listed in the Wall Street Journal as the top medical breakthrough of 2003 and used in the treatment of multiple myeloma. The basic research ICRF funds have led to treatments and drugs that are benefiting cancer patients around the world. (en)
schema:sameAs
skos:closeMatch
prov:wasDerivedFrom
page length (characters) of wiki page
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
is Wikipage redirect of
is Wikipage disambiguates of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git147 as of Sep 06 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3332 as of Dec 5 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 76 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software